ISOLATION OF VERY VIRULENT MAREKS-DISEASE VIRUSES FROM VACCINATED CHICKENS IN AUSTRALIA

被引:17
作者
MCKIMMBRESCHKIN, JL [1 ]
FARAGHER, JT [1 ]
WITHELL, J [1 ]
FORSYTH, WM [1 ]
机构
[1] NATL BIOL STAND LAB, PRIVATE BAG 7, PARKVILLE 3052, VIC, AUSTRALIA
关键词
D O I
10.1111/j.1751-0813.1990.tb07761.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Very virulent Marek's disease viruses (vvMDV), defined as isolates against which the herpesvirus of turkey (HVT) vaccine provide poor protection, have been isolated from poultry flocks in both the United States and Europe. Twenty-one samples from vaccinated Australian flocks, experiencing problems with excessive Marek's disease (MD), were tested for the presence of transmissible MD viruses (MDV). Of the 16 samples which contained a transmissible agent, 14 were pathogenic in chickens, based on the development of MD lesions or depression of the bursa/body weight ratio. Of the pathogenic isolates which have been successfully typed 10 were serotype 1, and one was serotype 2 MDV. Pathogenicity of isolates varied. Several isolates caused tumours in 20-30% of both vaccinated and unvaccinated chickens. Two isolates, MPF6 and MPF23, caused tumours in more than 50% of chickens. When MPF6 and MPF23 were tested in vaccine trials bivalent vaccine gave no better protection against development of MD lesions than a monovalent vaccine. Isolate MPF23 was so pathogenic that lesions were produced in all chickens, regardless of the vaccine protocol used. Therefore vvMDV have been isolated in Australia, and unlike the vaccines tested overseas, bivalent Australian vaccines do not appear to provide greater protection against these vvMDV.
引用
收藏
页码:205 / 209
页数:5
相关论文
共 31 条
[1]  
Bulow V V, 1975, Avian Pathol, V4, P147, DOI 10.1080/03079457509353860
[2]  
Bulow V V, 1975, Avian Pathol, V4, P133, DOI 10.1080/03079457509353859
[3]   FIELD TRIALS WITH A BIVALENT VACCINE (HVT AND SB-1) AGAINST MAREKS-DISEASE [J].
CALNEK, BW ;
SCHAT, KA ;
PECKHAM, MC ;
FABRICANT, J .
AVIAN DISEASES, 1983, 27 (03) :844-849
[4]  
CALNEK BW, 1980, ORCOGENIC HERPESVIRU, V103
[5]   PROTECTIVE EFFICACY OF MAREKS-DISEASE VIRUS (MDV) CVI-988 CEF65 CLONE-C AGAINST CHALLENGE INFECTION WITH 3 VERY VIRULENT MDV STRAINS [J].
DEBOER, GF ;
GROENENDAL, JE ;
BOERRIGTER, HM ;
KOK, GL ;
POL, JMA .
AVIAN DISEASES, 1986, 30 (02) :276-283
[6]   REDUCED VACCINAL PROTECTION OF TURKEY HERPESVIRUS AGAINST FIELD STRAINS OF MAREKS-DISEASE HERPESVIRUS [J].
EIDSON, CS ;
ELLIS, MN ;
KLEVEN, SH .
POULTRY SCIENCE, 1981, 60 (02) :317-322
[7]   CELL-FREE OR CELL-ASSOCIATED TURKEY HERPESVIRUS VACCINE AGAINST MAREKS-DISEASE IN CHICKENS AS INFLUENCED BY MATERNAL ANTIBODY, VACCINE DOSE, AND TIME OF EXPOSURE TO MAREKS-DISEASE VIRUS [J].
EIDSON, CS ;
PAGE, RK ;
KLEVEN, SH .
AVIAN DISEASES, 1978, 22 (04) :583-597
[8]   THE STRUCTURE OF MAREK DISEASE VIRUS-DNA - THE PRESENCE OF UNIQUE EXPANSION IN NONPATHOGENIC VIRAL-DNA [J].
FUKUCHI, K ;
TANAKA, A ;
SCHIERMAN, LW ;
WITTER, RL ;
NONOYAMA, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (03) :751-754
[9]   SIMILARITIES AND DISSIMILARITIES IN THE STRUCTURE AND EXPRESSION OF VIRAL GENOMES OF VARIOUS VIRUS-STRAINS IMMUNOLOGICALLY RELATED TO MAREKS-DISEASE VIRUS [J].
HIRAI, K ;
NAKAJIMA, K ;
IKUTA, K ;
KIRISAWA, R ;
KAWAKAMI, Y ;
MIKAMI, T ;
KATO, S .
ARCHIVES OF VIROLOGY, 1986, 89 (1-4) :113-130
[10]   STRUCTURAL-CHANGES OF THE DNA OF MAREKS-DISEASE VIRUS DURING SERIAL PASSAGE IN CULTURED-CELLS [J].
HIRAI, K ;
IKUTA, K ;
KATO, S .
VIROLOGY, 1981, 115 (02) :385-389